Notis McConarty Edward Grows Stake in UnitedHealth Group Incorporated $UNH

Notis McConarty Edward boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 11.9% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,837 shares of the healthcare conglomerate’s stock after purchasing an additional 941 shares during the period. UnitedHealth Group comprises 1.3% of Notis McConarty Edward’s investment portfolio, making the stock its 28th biggest position. Notis McConarty Edward’s holdings in UnitedHealth Group were worth $2,757,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the stock. Trifecta Capital Advisors LLC grew its holdings in UnitedHealth Group by 4.9% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 10,360 shares of the healthcare conglomerate’s stock valued at $3,232,000 after buying an additional 481 shares during the last quarter. Windle Wealth LLC acquired a new stake in UnitedHealth Group during the 2nd quarter valued at $220,000. Morey & Quinn Wealth Partners LLC boosted its holdings in shares of UnitedHealth Group by 4.5% during the second quarter. Morey & Quinn Wealth Partners LLC now owns 1,778 shares of the healthcare conglomerate’s stock worth $555,000 after purchasing an additional 77 shares during the last quarter. AMI Investment Management Inc. boosted its holdings in shares of UnitedHealth Group by 30.6% during the second quarter. AMI Investment Management Inc. now owns 8,470 shares of the healthcare conglomerate’s stock worth $2,642,000 after purchasing an additional 1,987 shares during the last quarter. Finally, Maryland State Retirement & Pension System boosted its holdings in shares of UnitedHealth Group by 2.6% during the second quarter. Maryland State Retirement & Pension System now owns 44,230 shares of the healthcare conglomerate’s stock worth $13,798,000 after purchasing an additional 1,122 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $369.88 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a market cap of $334.99 billion, a PE ratio of 16.03, a P/E/G ratio of 2.35 and a beta of 0.47. The stock has a 50 day simple moving average of $313.51 and a 200-day simple moving average of $352.54. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group’s quarterly revenue was up 12.9% on a year-over-year basis. During the same period in the prior year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is 38.30%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Royal Bank Of Canada decreased their price objective on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Wednesday. Piper Sandler dropped their target price on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 30th. Oppenheimer dropped their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Finally, UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $372.68.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.